Tag Archives: Partnership Advances Commercial Production of Actinium-225 for Next Generation Nuclear Medicine Applications

Eckert & Ziegler Expands Actinium-225 Production to Support Growing Demand for Targeted Cancer Therapies

(IN BRIEF) Eckert & Ziegler and the Nuclear Physics Institute of the Czech Academy of Sciences have scaled up production of the critical medical isotope Actinium-225, moving from development into larger-scale manufacturing at facilities in Řež and Braunschweig. The expansion … Read the full press release